Mark R. Rigby, MD, PhD - Senior Director Clinical Development, Innovative Medicines, Immunology TA, Teva Pharmacuticals - Teva Pharmaceuticals | LinkedIn
![CNS Antigen-Specific Neuroinflammation Attenuates Ischemic Stroke With Involvement of Polarized Myeloid Cells | Neurology Neuroimmunology & Neuroinflammation CNS Antigen-Specific Neuroinflammation Attenuates Ischemic Stroke With Involvement of Polarized Myeloid Cells | Neurology Neuroimmunology & Neuroinflammation](https://nn.neurology.org/content/nnn/9/4/e1168/F1.large.jpg)
CNS Antigen-Specific Neuroinflammation Attenuates Ischemic Stroke With Involvement of Polarized Myeloid Cells | Neurology Neuroimmunology & Neuroinflammation
![Iodine mediated in situ generation of R-Se–I: application towards the construction of pyrano[4,3- b ]quinoline heterocycles and fluorescence propertie ... - Organic & Biomolecular Chemistry (RSC Publishing) DOI:10.1039/C9OB01648A Iodine mediated in situ generation of R-Se–I: application towards the construction of pyrano[4,3- b ]quinoline heterocycles and fluorescence propertie ... - Organic & Biomolecular Chemistry (RSC Publishing) DOI:10.1039/C9OB01648A](https://pubs.rsc.org/image/article/2019/OB/c9ob01648a/c9ob01648a-u23_hi-res.gif)